Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Broker tips: Reckitt, FirstGroup, HSBC
(Sharecast News) - Analysts at Berenberg slashed their target price on household goods manufacturer Reckitt from 8,200.0p to 7,050.0p on Thursday but reiterated its 'buy' rating on the "still mispriced" stock. Berenberg noted that in Reckitt's third-quarter results it had reported group like-for-like sales growth of 7.4%, above visible alpha-compiled consensus of 6.2%, reflecting volume growth of -4.6% and price/mix of 12%.
The German bank said the beat was predominantly driven by the group's nutrition division, which achieved 24.7% like-for-like sales growth. In other divisions, hygiene declined by 1.2% and health like-for-like sales rose by 10.7%.
"These growth rates included: 1) the continued strong positive contribution from US infant formula, which grew around 40% yoy as key competitor Abbott still faced supply issues; 2) strong growth from the over-the-counter health categories, which grew c20% from share gains and a favourable cold and flu season in key markets in the southern hemisphere; and 3) a significant headwinds from Lysol, which declined 15% yoy due to a tough comparable and post-Covid-19 normalisation," said the analysts.
Berenberg stated that its 2023 growth assumptions for Reckitt reflected a recessionary backdrop, a full reversal of market share gains in US infant formula, potential cost headwinds from a rise in labour costs, and higher financing costs.
Liberum cut its price target on FirstGroup on Thursday to 165.0p from 180.0p as it said the earnout from the sale of First Transit fell "well short" of its "admittedly bullish" assumption.
FirstGroup said on Wednesday that as part of the sale of First Transit to EQT Infrastructure, it is entitled to an estimated earnout consideration of around $85.0m.
Liberum said this is well below the carrying value of £106.0m, so will result in a loss on disposal. It is also well below its assumption of £180.0m within its sum-of-the-parts valuation.
"We had previously envisaged near-term positive catalysts from the crystallisation of value from the residual Greyhound balance sheet and the Transit earnout," Liberum said.
"Both of these have come through, with Greyhound slightly better than expected but Transit much worse than hoped for. The remaining catalysts remain longer-term, and/or less specific."
Analysts at Deutsche Bank raised their target price on banking giant HSBC from 570.0p to 650.0p on Thursday after the group's new guidance included an upgrade to consensus.
Deutsche Bank said HSBC's new guidance was an upgrade to consensus, despite the stock's "significant" share price underperformance on Wednesday.
However, the German bank said the negative foreign currency translation on revenues was more than offset by higher trading income as rates rise and from the FX translation on costs.
"Impairment guidance for 2023 at the upper end of normalised range but on lower loan growth also leads to additional upgrades," said DB, which reiterated its 'hold' rating on the stock. "On a pre-provision basis, our estimates are 4% better than consensus and 5% post-provision."
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.